The latest issue of the Alimentary Pharmacology & Therapeutics develops a nomogram for predicting prognostic value of inflammatory response biomarkers in decompensated cirrhotic patients without acute-on-chronic liver failure.
This month's issue of the American Journal of Gastroenterology outlines the mechanisms by which central neuromodulators work, the differences between classes and individual agents, and the various adverse effects.
A study published in May's issue of the Alimentary Pharmacology & Therapeutics evaluates the short- and long-term impact of Clostridium difficile infection on risk of colectomy in inflammatory bowel disease.
Published ahead of print, the Alimentary Pharmacology & Therapeutics reports that risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients.
A study in this month's issue of the Annals of Internal Medicine summarizes published literature on the efficacy and safety of oral direct-acting antivirals for treatment of persons with chronic HCV infection.